Women’s Health is a branch of medicine that focuses on the prevention and diagnosis of diseases that have an impact on a woman's physical and emotional well-being. It includes a wide range of treatments, drugs, and surgical products for diseases related to women.

The Women’s Health Market was valued at ~$38 billion in 2021 and is expected to grow at a CAGR of over ~4.5% to cross $47 billion by 2026. This growth will be fueled by the rising prevalence of women-centric diseases (such as endometriosis, osteoporosis, breast cancer, menopause), the introduction of innovative new products for women’s health, government initiatives to curb population growth, and growing demand for contraceptives to avoid unwanted pregnancies.

Emerging Opportunities in Women’s Health Market

One of the main factors influencing the women's health market is the increased incidence of infectious and chronic diseases among a significant portion of the female population. Recent advances in genomics, tissue engineering, artificial intelligence, and cell and gene therapy have synergized a new wave of healthcare innovations that may be used to develop products and treatments specific to the diseases that affect women.

For example, researchers are studying transcriptomics (the study of RNA molecules in a cell) for treating elusive conditions such as preeclampsia or preterm birth. Another area of research that can assist researchers in achieving the potential of personalized medicine is genomics. There has been extraordinary growth in terms of technology from predictive AI solutions to modeling unique DNA profiles. An environment that is favorable to research activities is anticipated to fuel more growth opportunities in this market.

“Women’s health is not a niche market; it includes much more than just maternal or reproductive care. Indeed, women’s healthcare presents enormous opportunities for value creation and for improving the lives and livelihoods of women, with positive effects that redound across society.”- Executive Vice President, Global Operations and Supply Chain, Women’s Health Company, United States

Key Challenges/ Constraints: Women’s Health Market

The high cost associated with clinical care in some countries and side effects associated with the usage of few women's health drugs (such as night sweats, headache, nausea, and difficulty sleeping) is likely to restrain the growth of the women’s health market.

North America: The Largest Women’s Health Market

North America has the major women’s health market, followed by Europe and APAC. The large share of North America can be attributed to the strong economies of the US and Canada, established reimbursement policies, early approval & commercialization of products, and the presence of key market players in this region. APAC holds a minor share in the global market.

Explore Premium Report on Women’s Health Market @ https://meditechinsights.com/global-womens-health-market/

Key Market Trends: Women’s Health Market

The women’s health market is a quite stable but competitive market noticeable by the presence of both established and new players. Players operating in the market adopt both organic and inorganic growth strategies such as collaborations and acquisitions to garner market share.

For instance,

• In March 2022, Carlyle Group Inc. and PAI Partners announced the acquisitions of women’s health business Theramex from private equity firm CVC Capital Partners.
• In November 2021, Organon announced the acquisition of Forendo Pharma, a clinical-stage drug development company focused on novel treatments for women’s health.

During the forecast period, inorganic developments like acquisitions and collaborations are anticipated to drive the women's health market.

The growth prospects of the market look promising given strategic collaborations & acquisitions, favorable regulatory landscape, and rise in investments from private equity, venture capitalists, and government globally, new product launches, and advances in R&D to build a robust product pipeline by players.

Competitive Landscape Analysis of Women’s Health Market

Some of the key players operating in the global women’s health market are AbbVie Inc, Eli Lilly, Pfizer Inc., Merck & Co., Ferring Pharmaceuticals, LUPIN, Bayer AG, AstraZeneca, Novartis AG, Mithra Pharmaceuticals, Allergan, among others.

For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

[email protected]